Emily Pimblett - Sep 18, 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Emily Pimblett
Stock symbol
ELYM
Transactions as of
Sep 18, 2024
Transactions value $
-$9,741
Form type
4
Date filed
9/20/2024, 09:53 PM
Previous filing
Jun 21, 2024
Next filing
Dec 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELYM Common Stock Options Exercise +5K +133.16% 8.76K Sep 18, 2024 Direct F1
transaction ELYM Common Stock Sale -$9.67K -1.18K -13.5% $8.18 7.57K Sep 20, 2024 Direct F2
transaction ELYM Common Stock Sale -$73 -9 -0.12% $8.06 7.56K Sep 20, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Restricted Stock Units Options Exercise $0 -5K -14.29% $0.00 30K Sep 18, 2024 Common Stock 5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
F2 The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 27, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.